Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,678 | -98,591 | -71,434 | -48,039 | -24,454 |
| Depreciation Amortization | 823 | 3,847 | 2,665 | 1,539 | 543 |
| Other Working Capital | -2,392 | 6,676 | 7,225 | 4,110 | -88 |
| Other Operating Activity | 933 | 31,002 | 22,272 | 21,845 | 7,440 |
| Operating Cash Flow | $-24,314 | $-57,066 | $-39,272 | $-20,545 | $-16,559 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 41,450 | -229,863 | -251,458 | -236,362 | -190,463 |
| PPE Investments | -605 | -2,338 | -1,776 | -761 | -58 |
| Investing Cash Flow | $40,845 | $-232,201 | $-253,234 | $-237,123 | $-190,521 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 107 | 14,890 | 14,395 | 14,210 | 129 |
| Other Financing Activity | 0 | 296,218 | 296,218 | 296,218 | 296,890 |
| Financing Cash Flow | $107 | $311,108 | $310,613 | $310,428 | $297,019 |
| Beginning Cash Position | 28,948 | 7,107 | 7,107 | 7,107 | 7,107 |
| End Cash Position | 45,586 | 28,948 | 25,214 | 59,867 | 97,046 |
| Net Cash Flow | $16,638 | $21,841 | $18,107 | $52,760 | $89,939 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,314 | -57,066 | -39,272 | -20,545 | -16,559 |
| Capital Expenditure | -605 | -2,338 | -1,776 | -761 | -58 |
| Free Cash Flow | -24,919 | -59,404 | -41,048 | -21,306 | -16,617 |